Dr. Stephanie J. Jeske, MD, MS

Dr. Jeske practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Jeske's NPI, 1194942813, was assigned on April 20, 2007. Dr. Jeske graduated from Indiana University School Of Medicine in 2003. Dr. Jeske's California license number on file is A111486.

Dr. Jeske's primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Jeske's primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. Dr. Jeske is also affiliated with Mills-Peninsula Medical Center. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Jeske to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jeske practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jeske's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jeske is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Jeske's licenses on file in 3 states: California, New York and Michigan.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Jeske treats.

CMS data shows 3,295 Medicare services from Dr. Jeske across 11 procedure codes in 2024, for 388 Medicare patients. Medicare paid $137,259 for them. Every service was in an office.

CMS counts 388 Medicare patients who saw Dr. Jeske in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have cancer, and 68% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jeske's median patient age at 64, with 85% women.

In 2024, Dr. Jeske wrote 1,099 Medicare Part D claims for 297 patients. 87% of them were for generic drugs. CMS names the drug for 956 of them, across 10 drugs with 11 or more claims each, at $821,536 in total drug cost. In 2023, CMS named 942 claims across 15 drugs.

Dr. Jeske accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jeske as offering telehealth.

Dmand AI links 3 papers to Dr. Jeske in 2010. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Jeske's most frequent co-authors are David M. Nanus, MD, Scott T. Tagawa, MD and Max W. Sung.

Dmand AI links Dr. Jeske to 1 clinical trial. Conditions studied include Pancreatic cancer, adult and Pancreatic Neoplasms.

CMS Open Payments shows 44 general payments to Dr. Jeske from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Merrimack Pharmaceuticals, Inc. paid the most, $1,137.

Dmand AI lists 1 award for Dr. Jeske, most recently CMS Stage 1 2012 in 2011.

Dr. Jeske graduated from Indiana University School Of Medicine in 2003. Dr. Jeske is a member of ACP, ASCO and ASH.

Dr. Jeske is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.